Please login to the form below

Not currently logged in
Email:
Password:

antbody-drug conjugates

This page shows the latest antbody-drug conjugates news and features for those working in and with pharma, biotech and healthcare.

Merck KGaA furthers antibody ambitions in cancer

Merck KGaA furthers antibody ambitions in cancer

Signs deal with Mersana to develop antibody-drug conjugates. Germany's Merck KGaA is keeping the pressure on its rivals in oncology by signing a deal with US-based biotech Mersana ... Merck, via its biopharma division Merck Serono, will use Mersana's

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics